Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

404 ARTÍCULOS , VIENDO DEL 331 AL 345

Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery

Hampel H, Vergallo A, Caraci F, Cuello AC, Lemercier P, Vellas B, Giudici KV, Baldacci F, Hänisch B, Haberkamp M, Broich K, Nisticò R, Emanuele E, Llavero F, Zugaza JL, Lucía A, Giacobini E, Lista S; Alzheimer Precision Medicine Initiative.

Neuropharmacology. 2021 Mar 1;185:108081. doi: 10.1016/j.neuropharm.2020.108081. Epub 2020 May 11.

Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate

van Dyck CH, Arnsten AFT, Padala PR, Brawman-Mintzer O, Lerner AJ, Porsteinsson AP, Scherer RW, Levey AI, Herrmann N, Jamil N, Mintzer JE, Lanctôt KL, Rosenberg PB.

Am J Geriatr Psychiatry. 2021 Jan;29(1):51-62. doi: 10.1016/j.jagp.2020.04.026. Epub 2020 May 5.

Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments

Lanctôt KL, Scherer RW, Li A, Vieira D, Coulibaly H, Rosenberg PB, Herrmann N, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, Mintzer JE.

Am J Geriatr Psychiatry. 2021 Jan;29(1):81-89. doi: 10.1016/j.jagp.2020.05.020. Epub 2020 May 27.

Cerebrospinal Fluid Amyloid Beta, Tau Levels, Apolipoprotein, and (1)H-MRS Brain Metabolites in Alzheimer's Disease: A Systematic Review

Piersson AD, Mohamad M, Rajab F, Suppiah S.

Acad Radiol. 2021 Oct;28(10):1447-1463. doi: 10.1016/j.acra.2020.06.006. Epub 2020 Jul 7.

Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients

Vidoni ED, Choi IY, Lee P, Reed G, Zhang N, Pleen J, Mahnken JD, Clutton J, Becker A, Sherry E, Bothwell R, Anderson H, Harris RA, Brooks W, Wilkins HM, Mosconi L, Burns JM, Swerdlow RH.

Alzheimers Dement. 2021 Jan;17(1):7-17. doi: 10.1002/alz.12156. Epub 2020 Jul 27.

The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer's disease

Lau HHC, Ingelsson M, Watts JC.

Acta Neuropathol. 2021 Jul;142(1):17-39. doi: 10.1007/s00401-020-02201-2. Epub 2020 Aug 2.

Unblinded by the light: amyloid-related imaging abnormalities in Alzheimer's clinical trials

Gleason A, Ayton S, Bush AI.

Eur J Neurol. 2021 Jan;28(1):e1. doi: 10.1111/ene.14484. Epub 2020 Sep 9.

Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia

Scuteri D, Vulnera M, Piro B, Bossio RB, Morrone LA, Sandrini G, Tamburin S, Tonin P, Bagetta G, Corasaniti MT.

Eur J Clin Pharmacol. 2021 Feb;77(2):241-249. doi: 10.1007/s00228-020-02995-w. Epub 2020 Sep 15.

The development of new method to differentiate between Dementia with Lewy bodies and Alzheimer's disease by cerebral perfusion SPECT-comparison to CIScore

Honda G, Nagamachi S, Nonokuma M, Takano K, Kuwabara Y, Yoshimitsu K, Iida H, Ogomori K, Kawasaki H, Tsuboi Y.

Jpn J Radiol. 2021 Feb;39(2):198-205. doi: 10.1007/s11604-020-01041-0. Epub 2020 Sep 16.

Transitioning to Long-Term Care: Family Caregiver Experiences of Dementia, Communities, and Counseling

Zmora R, Statz TL, Birkeland RW, McCarron HR, Finlay JM, Rosebush CE, Gaugler JE.

J Aging Health. 2021 Jan;33(1-2):133-146. doi: 10.1177/0898264320963588. Epub 2020 Sep 29.

Linking the Mini-Mental State Examination, the Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Severe Impairment Battery: evidence from individual participant data from five randomised clinical trials of donepezil

Levine SZ, Yoshida K, Goldberg Y, Samara M, Cipriani A, Efthimiou O, Iwatsubo T, Leucht S, Furukawa TA.

Evid Based Ment Health. 2021 May;24(2):56-61. doi: 10.1136/ebmental-2020-300184. Epub 2020 Oct 6.

Evaluation of Discriminative Detection Abilities of Social Cognition Measures for the Diagnosis of the Behavioral Variant of Frontotemporal Dementia: a Systematic Review

Dodich A, Crespi C, Santi GC, Cappa SF, Cerami C.

Neuropsychol Rev. 2021 Jun;31(2):251-266. doi: 10.1007/s11065-020-09457-1. Epub 2020 Oct 10.

Alzheimer's Disease Screening Tools for Asian Americans: A Scoping Review

Lim S, Chong S, Min D, Mohaimin S, Roberts T, Trinh-Shevrin C, Kwon SC.

J Appl Gerontol. 2021 Oct;40(10):1389-1398. doi: 10.1177/0733464820967594. Epub 2020 Oct 26.

The promise of artificial neural networks, EEG, and MRI for Alzheimer's disease

Bailey NW, Hoy KE.

Clin Neurophysiol. 2021 Jan;132(1):207-209. doi: 10.1016/j.clinph.2020.10.009. Epub 2020 Oct 29.

New MAPT variant in a FTD patient with Alzheimer's disease phenotype at onset

Caroppo P, Prioni S, Maderna E, Grisoli M, Rossi G.

Neurol Sci. 2021 May;42(5):2111-2114. doi: 10.1007/s10072-020-04901-9. Epub 2020 Nov 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias